Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection

J Hepatol. 2017 Jan;66(1):242-243. doi: 10.1016/j.jhep.2016.09.014. Epub 2016 Oct 1.

Authors

Marc van der Valk¹, Hans L Zaaijer², Arnon P Kater³, Janke Schinkel²

Affiliations

¹ Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam (CINIMA), The Netherlands. Electronic address: m.vandervalk@amc.uva.nl.
² Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 27702641
DOI: 10.1016/j.jhep.2016.09.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use
Drug Resistance, Viral / genetics
Drug Therapy, Combination
Hepatitis E / drug therapy*
Hepatitis E / virology
Hepatitis E virus / drug effects
Hepatitis E virus / genetics
Hepatitis, Chronic / drug therapy
Hepatitis, Chronic / virology
Humans
Male
Middle Aged
Ribavirin / administration & dosage
Ribavirin / therapeutic use
Sofosbuvir / administration & dosage
Sofosbuvir / therapeutic use*

Substances

Antiviral Agents
Ribavirin
Sofosbuvir